| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |